These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21851395)

  • 1. Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?
    Yalamanchili V; Reilly RF
    Semin Dial; 2011; 24(4):387-8. PubMed ID: 21851395
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atrial fibrillation: anticoagulants or not?].
    Zimmermann M
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1560-5. PubMed ID: 7939523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coumarin use in dialysis patients with atrial [corrected] fibrillation: yes, after individual risk stratification.
    Hörl WH
    Nephrol Dial Transplant; 2009 Nov; 24(11):3285-7. PubMed ID: 19666666
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulation in renal failure].
    Strutz F; Müller GA
    Internist (Berl); 1999 Feb; 40(2):214-6. PubMed ID: 10097981
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ; Lim JK
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage renal disease with atrial fibrillation: uncharted territory in the modern world of anticoagulants.
    Browne SD; McMaster J; Rizvi SA; Ahmed S
    Expert Opin Pharmacother; 2014 Aug; 15(12):1639-42. PubMed ID: 25032883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation control in atrial fibrillation: optimizing risks and benefits.
    Alsheikh-Ali AA; Estes NA
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):72-3. PubMed ID: 20031792
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and atrial fibrillation.
    Atwood JE; Albers GW
    Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilemmas in the management of atrial fibrillation in chronic kidney disease.
    Reinecke H; Brand E; Mesters R; Schäbitz WR; Fisher M; Pavenstädt H; Breithardt G
    J Am Soc Nephrol; 2009 Apr; 20(4):705-11. PubMed ID: 19092127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision.
    Singer DE
    Proc Assoc Am Physicians; 1996 Jan; 108(1):29-36. PubMed ID: 8834062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
    Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
    N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing stroke in atrial fibrillation.
    Wolf PA; Singer DE
    Am Fam Physician; 1997 Dec; 56(9):2242-50. PubMed ID: 9402810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of atrial fibrillation among patients with end-stage renal disease.
    Chou CY; Kuo HL; Wang SM; Liu JH; Lin HH; Liu YL; Huang CC
    Nephrol Dial Transplant; 2010 Apr; 25(4):1225-30. PubMed ID: 19923144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk.
    Marinigh R; Lane DA; Lip GY
    J Am Coll Cardiol; 2011 Mar; 57(12):1339-48. PubMed ID: 21414530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of anticoagulant therapy in atrial fibrillation.
    Kottkamp H; Hindricks G; Breithardt G
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S86-96. PubMed ID: 9727682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation in patients with atrial fibrillation].
    Mügge A
    Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
    Lip GY
    Thromb Haemost; 2010 Apr; 103(4):683-5. PubMed ID: 20135056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.